Chronic pain resulting from inflammatory and neuropathic disorders causes considerable economic and social burden. In particular in the orthopaedic field, musculoskeletal pain is one of the most predominant kinds of chronic pain and its prevalence is increasing. Pharmacological therapies currently available for certain types of pain are only partially effective and may cause severe adverse side effects. Pharmacological results of this study support that the allosteric blockade of the C5aR represents a highly promising therapeutic approach to control chronic inflammatory and neuropathic pain.

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief / A. Moriconi, T. Cunha, G. Souza, A. Lopes, F. Cunha, V. Carneiro, L. Pinto, L. Brandolini, A. Aramini, C. Bizzarri, G. Bianchini, A. Beccari, M. Fanton, A. Bruno, G. Costantino, R. Bertini, E. Galliera, M. Locati, S. Ferreira, M. Teixeira, M. Allegretti. - In: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. - ISSN 0027-8424. - 111:47(2014 Nov 25), pp. 16937-16942.

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief

G. Bianchini;E. Galliera;M. Locati;
2014

Abstract

Chronic pain resulting from inflammatory and neuropathic disorders causes considerable economic and social burden. In particular in the orthopaedic field, musculoskeletal pain is one of the most predominant kinds of chronic pain and its prevalence is increasing. Pharmacological therapies currently available for certain types of pain are only partially effective and may cause severe adverse side effects. Pharmacological results of this study support that the allosteric blockade of the C5aR represents a highly promising therapeutic approach to control chronic inflammatory and neuropathic pain.
C5a; inflammatory pain; neuropathic pain; allosteric antagonism; GPCR
Settore MED/05 - Patologia Clinica
25-nov-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
PNAS-2014-Moriconi-16937-42.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.18 MB
Formato Adobe PDF
2.18 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/279268
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 51
social impact